12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers GeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday’s after-market session. The market value of…
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
Top 5 Health Care Stocks That May Plunge In March
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Inozyme Pharma Highlights Inclusion Of Generalized Arterial Calcification Of Infancy In Genomics England’s Generation Study Of Rare Conditions
Inozyme Pharma, Inc. (NASDAQ:INZY) ("Inozyme" or the "Company"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal
6 Analysts Have This to Say About Inozyme Pharma
Inozyme Pharma (NASDAQ:INZY) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Inozyme Pharma Posts Encouraging Data From Rare Calcification Disorders
Inozyme Pharma Inc (NASDAQ: INZY) announced interim safety, pharmacokinetic (PK), pharmacodynamic (PD), and exploratory efficacy data from its ongoing Phase 1/2 trials of INZ-701 in adults with
Inozyme Pharma Announces Interim Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE)
Inozyme Pharma, Inc. (NASDAQ:INZY) ("Inozyme" or the "Company"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Femasys (NASDAQ:FEMY) shares moved upwards by 56.8% to $0.52 during Monday’s after-market session. This security traded at…
Analyst Expectations for Inozyme Pharma’s Future
Analysts have provided the following ratings for Inozyme Pharma (NASDAQ:INZY) within the last quarter: Bullish Somewhat Bullish Indifferent…
4 Analysts Have This to Say About Inozyme Pharma
Over the past 3 months, 4 analysts have published their opinion on Inozyme Pharma (NASDAQ:INZY) stock. These analysts…